A tropical fungus, Cryptococcus gattii, introduced to Pacific Northwest waters via ship ballast from Brazil, was spread inland by the 1964 Alaska tsunami and adapted over 30 years to infect people on land by the 1990s.
Where this was said
At 25:20 · chapter starts 25:10
If one story crystallises how far-reaching the 1964 earthquake's consequences were, it's the fungus. Cryptococcus gattii is a microscopic fungus native to the tropics, where it grows on rotting wood and can cause fatal infections in humans. It has no business being in Alaska or the Pacific Northwest. Yet around the turn of the 20th century, a ship travelling from Brazil to Vancouver discharged its ballast water into the Pacific — and with it, the fungus [1] — Chuck "Cryptococcus gattii, a tropical fungus that only grows on rotting wood, was introduced to Pacific Northwest waters via ship ballast from Br…" 25:05 . It survived in the seawater, largely unnoticed, for decades. Then the 1964 tsunami came and drove it inland, spreading it across new terrestrial habitats. In its new environment, the fungus began adapting. For 30 years it worked, quietly and invisibly. By the 1990s, it had successfully adapted to life on land in the Pacific Northwest and began infecting people — triggering a mysterious outbreak that baffled public health officials, because by all logic, Cryptococcus gattii simply should not be there. An epidemiologist eventually traced the chain: ship ballast, seawater survival, tsunami dispersal, three decades of adaptation. The 1964 earthquake, in ways nobody anticipated, was still having consequences 30 years later.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.